Selective RET Inhibition in Metastatic RET-Mutant Medullary Thyroid Cancer and RET Fusion–Positive Differentiated Thyroid Cancer

Downloadable slideset from a live meeting series for endocrinologists featuring best practices for biomarker testing and the latest evidence on targeted therapies for advanced thyroid cancer, from Clinical Care Options (CCO)

Maria E Cabanillas, MD Lori J. Wirth, MD Released: January 4, 2023

Downloadable slideset from a workshop series from Clinical Care Options (CCO) on the management of NTRK and RET-altered lung and thyroid cancer

Saad A. Khan, MD Sandip P. Patel, MD Released: November 17, 2022

Downloadable resource on the role of RET and NTRK aberrations in lung and thyroid cancer, including guidance on testing and review of the clinical data on RET and NTRK inhibitor therapy for these diseases, from Clinical Care Options (CCO)

Video featuring pathology experts discussing molecular testing in lung and thyroid cancers, from Clinical Care Options (CCO)

Juan C. Hernandez-Prera, MD Jeremy P. Segal, MD, PhD Physicians: maximum of 0.5 AMA PRA Category 1 Credits™ ABIM MOC: maximum of 0.5 Medical Knowledge MOC points ABPath MOC: maximum of 0.5 Lifelong Learning points Released: October 24, 2022 Expired: October 23, 2023